National Institute of Mental Health
Organisation
Trials
fMRI Studies of Memory and Perception
CollaboratorNo phaseRecruiting2026170 people6 Oct 2026clinicaltrials.gov
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy Volunteers
Phase 1Recruiting202640 people2 Oct 2026clinicaltrials.gov
CollaboratorEarly phase 1Recruiting202680 people1 May 2026clinicaltrials.gov
Phase 1Recruiting202690 people12 Sept 2025clinicaltrials.gov
CollaboratorPhase 1/2Not yet recruiting2026144 people15 Aug 2025clinicaltrials.gov
CollaboratorNo phaseCompleted2025161 people20 Jul 2025clinicaltrials.gov
CollaboratorPhase 2Recruiting202575 people30 Aug 2024clinicaltrials.gov
CollaboratorPhase 2Recruiting202450 people26 Jan 2024clinicaltrials.gov
CollaboratorPhase 4Completed201987 people8 Sept 2022clinicaltrials.gov
CollaboratorPhase 1Completed202296 people6 Jun 2022clinicaltrials.gov
CollaboratorPhase 4Completed202240 people24 May 2022clinicaltrials.gov
Phase 2Terminated20227 people30 Sept 2021clinicaltrials.gov
CollaboratorPhase 2Completed202010 people13 Jan 2020clinicaltrials.gov
CollaboratorPhase 3Completed202083 people10 Dec 2019clinicaltrials.gov
CollaboratorPhase 2Completed202023 people9 Aug 2019clinicaltrials.gov
CollaboratorEarly phase 1Completed2019127 people4 Jun 2019clinicaltrials.gov
Phase 1Terminated201931 people11 Apr 2019clinicaltrials.gov
CollaboratorPhase 1/2Completed202057 people30 Nov 2018clinicaltrials.gov
Phase 2Completed201974 people28 Sept 2018clinicaltrials.gov
CollaboratorEarly phase 1Terminated201859 people15 Jun 2018clinicaltrials.gov
Awards made
R01PREMAP - Predictors and Risk Evaluation for Menopause-Associated PsychosisR01MH1317682023–202717 Sept 2026reporter.nih.gov
R01PREMAP - Predictors and Risk Evaluation for Menopause-Associated PsychosisR01MH131768US$415.1k2023–202717 Sept 2026reporter.nih.gov
K01BIOLOGICAL AGING AND COGNITIVE IMPAIRMENT IN PERSONS WITH HIVK01MH1368622024–202917 Sept 2026reporter.nih.gov
K01BIOLOGICAL AGING AND COGNITIVE IMPAIRMENT IN PERSONS WITH HIVK01MH136862US$173.1k2024–202917 Sept 2026reporter.nih.gov
K23Optimizing Care to Prevent Diabetes and Promote Cardiovascular Health Among Younger Adults with Severe Mental IllnessK23MH1260782022–202717 Sept 2026reporter.nih.gov
Kaiser Foundation Research Institute
K23Optimizing Care to Prevent Diabetes and Promote Cardiovascular Health Among Younger Adults with Severe Mental IllnessK23MH126078US$188.3k2022–202717 Sept 2026reporter.nih.gov
R01Targeting Insomnia to Prevent Depression in the Menopause TransitionR01MH1415372026–203117 Sept 2026reporter.nih.gov
R01Targeting Insomnia to Prevent Depression in the Menopause TransitionR01MH1415372026–203117 Sept 2026reporter.nih.gov
R01Targeting Insomnia to Prevent Depression in the Menopause TransitionR01MH141537US$1.3m2026–203117 Sept 2026reporter.nih.gov
R01Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stageR01MH1286172022–202716 Sept 2026reporter.nih.gov
R01Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stageR01MH1286172022–202716 Sept 2026reporter.nih.gov
Beth Israel Deaconess Medical Center
R01Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stageR01MH128617US$900.5k2022–202716 Sept 2026reporter.nih.gov
R01Gene x Ovarian Hormone Interactions in Perimenopausal Risk for PsychosisR01MH1405272026–203110 Sept 2026reporter.nih.gov
R01Gene x Ovarian Hormone Interactions in Perimenopausal Risk for PsychosisR01MH1405272026–203110 Sept 2026reporter.nih.gov
R01Gene x Ovarian Hormone Interactions in Perimenopausal Risk for PsychosisR01MH1405272026–203110 Sept 2026reporter.nih.gov
R01Gene x Ovarian Hormone Interactions in Perimenopausal Risk for PsychosisR01MH1405272026–203110 Sept 2026reporter.nih.gov
R01Gene x Ovarian Hormone Interactions in Perimenopausal Risk for PsychosisR01MH140527US$796.1k2026–203110 Sept 2026reporter.nih.gov
R01Aging with Schizophrenia: A Multi-site Investigation of the Effects of Sleep Disturbances on Brain Connectivity and Cognitive FunctioningR01MH1400052026–20319 Sept 2026reporter.nih.gov
R01Aging with Schizophrenia: A Multi-site Investigation of the Effects of Sleep Disturbances on Brain Connectivity and Cognitive FunctioningR01MH1400052026–20319 Sept 2026reporter.nih.gov
R01Aging with Schizophrenia: A Multi-site Investigation of the Effects of Sleep Disturbances on Brain Connectivity and Cognitive FunctioningR01MH140005US$775.8k2026–20319 Sept 2026reporter.nih.gov
Funded papers
Association between plasma brain-derived p-tau variants and anxiety phenotypes in older adults
R01 MH108509, T32 MH0199865 Oct 2026api.crossref.org
R01MH1256672 Oct 2026pubmed.ncbi.nlm.nih.gov
R01MH13480924 Sept 2026api.crossref.org
R01MH13154218 Sept 2026pubmed.ncbi.nlm.nih.gov
Cardiovascular health and depression among postpartum women in the United States
R01MH12031318 Jul 2026api.crossref.org
Censoring-Aware Reinforcement Learning to Optimize Early Risk Alerts from Longitudinal Clinical Data
K01MH1273091 Jan 2026pubmed.ncbi.nlm.nih.gov